BioInvent International AB at Redeye Fight Cancer Seminar (Virtual) Transcript
Welcome to Redeye's Fight Cancer Day. Now it's time for BioInvent with CEO, Martin Welschof, to present the company. So welcome, Martin.
Good morning, Richard. So shall I just take it ahead?
Yes, please go ahead.
Okay, very well. So good morning, everybody. And as usual, I will start with a couple of introductory slides.
So BioInvent is focusing on translating cancer biology into innovative immuno-oncology therapies. And I will explain that to you a little bit more in detail later. We're based in Lund, Sweden, listed in Stockholm, and currently around 100 employees.
So as I mentioned on the previous slide, so we're pushing ahead with innovative immuno-oncology therapies, which are based on multiple modes of action. We have a broad portfolio, which I will introduce to you later.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |